Analystreport

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) was downgraded by analysts at Northland Capmk from a "strong-buy" rating to a "hold" rating.

Oncternal Therapeutics, Inc.  (ONCT) 
Last oncternal therapeutics, inc. earnings: 8/8 04:01 pm Check Earnings Report